{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:25:56Z","timestamp":1773300356023,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jash.2014.04.011","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T11:22:03Z","timestamp":1399634523000},"page":"475-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans"],"prefix":"10.1016","volume":"8","author":[{"given":"Cheryl L.","family":"Laffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Elijovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7798-7155","authenticated-orcid":false,"given":"George J.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Howard","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2014.04.011_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jash.2014.04.011_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/hr.2011.8","article-title":"A common polymorphism of CYP4A11 is associated with blood pressure in a Chinese population","volume":"34","author":"Zhang","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2014.04.011_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.0000151309.82473.59","article-title":"Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension","volume":"111","author":"Gainer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2014.04.011_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.HYP.0000182658.04299.15","article-title":"Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy","volume":"46","author":"Mayer","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2014.04.011_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.atherosclerosis.2009.06.009","article-title":"CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease\u2013The ENCORE Trials","volume":"207","author":"Hermann","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jash.2014.04.011_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.2008010063","article-title":"Association of a CYP4A11 variant and blood pressure in black men","volume":"19","author":"Gainer","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jash.2014.04.011_bib7","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/HJH.0b013e32834aa786","article-title":"CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow","volume":"29","author":"Williams","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2014.04.011_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1172\/JCI27546","article-title":"Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel","volume":"116","author":"Nakagawa","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2014.04.011_bib9","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1073\/pnas.92.25.11495","article-title":"A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity","volume":"92","author":"Hansson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jash.2014.04.011_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng0995-76","article-title":"Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome","volume":"11","author":"Hansson","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jash.2014.04.011_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2014.04.011_bib12","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1172\/JCI107001","article-title":"Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion","volume":"51","author":"Dluhy","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jash.2014.04.011_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/hy1101.095010","article-title":"Blood pressure responses to small doses of amiloride and spironolactone in normotensive subjects","volume":"38","author":"Pratt","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2014.04.011_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jash.2014.04.011_bib15","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/HJH.0b013e32832c7d23","article-title":"Aberrant ENaC activation in Dahl salt-sensitive rats","volume":"27","author":"Kakizoe","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2014.04.011_bib16","doi-asserted-by":"crossref","first-page":"F1764","DOI":"10.1152\/ajprenal.90525.2008","article-title":"Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury","volume":"295","author":"Williams","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jash.2014.04.011_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.27.3.481","article-title":"Salt sensitivity of blood pressure in humans","volume":"27","author":"Weinberger","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2014.04.011_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.HYP.34.4.631","article-title":"Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension","volume":"34","author":"Ambrosius","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2014.04.011_bib19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(97)07306-6","article-title":"Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London","volume":"351","author":"Baker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2014.04.011_bib20","doi-asserted-by":"crossref","first-page":"23527","DOI":"10.1074\/jbc.R109.025049","article-title":"Epithelial Na+ channel (ENaC), hormones, and hypertension","volume":"285","author":"Bubien","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jash.2014.04.011_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2014.04.011_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","article-title":"Effects of eplerenone versus losartan in patients with low-renin hypertension","volume":"150","author":"Weinberger","year":"2005","journal-title":"Am Heart J"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171114005464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171114005464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T04:21:45Z","timestamp":1538626905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171114005464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1933171114005464"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2014.04.011","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2014.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}